In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SeaSpine Holdings Corp.

www.seaspine.com

Latest From SeaSpine Holdings Corp.

Medtech Rises To Challenge Of Meeting Infinite Heath Care Demand With Finite Resources

The relative absence of blockbuster M&A within medtech in 2018, compared with recent years, does not mean that consolidation of the industry – and of providers and payers – will not continue apace in 2019 and beyond. In fact, it is written – if not in the stars then possibly in digital coding – that there will be fewer and bigger entities at the top end of the ecosystem of medtech stakeholders. And rising demand will be met more and more by digital tools and functionalities.

Commercial Healthcare Systems

Medtech Rises To Challenge Of Meeting Infinite Heath Care Demand With Finite Resources

The relative absence of blockbuster M&A within medtech in 2018, compared with recent years, does not mean that consolidation of the industry – and of providers and payers – will not continue apace in 2019 and beyond. In fact, it is written – if not in the stars then possibly in digital coding – that there will be fewer and bigger entities at the top end of the ecosystem of medtech stakeholders. And rising demand will be met more and more by digital tools and functionalities.

Outlook 2019 Medical Device

Medtechs At The Wheel In New Health Care Landscape

2016 was a year of surprise and change in political circles, but that's nothing new for the medtech industry, which over a number of years has become accustomed to health care systems demanding different and ever-higher levels of service. Smart medtechs have been ahead of the curve, but the whole industry now factors in clients' wider needs in a holistic approach to patient care. Many companies' current M&A policies are already reflecting the changes to come.

M & A Deals

Deals In Depth: August 2016

Pfizer signed multiple billion-dollar deals, including buying AstraZeneca's anti-infectives portfolio for $1.6 billion and acquiring Medivation – and the blockbuster cancer drug Xtandi – for $14 billion. Follow-on public offerings accounted for 52% of both biopharma and device financing.

Deals BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SeaSpine Holdings Corp.
  • Senior Management
  • Keith C Valentine, Pres. & CEO
    John J Bostjancic, SVP, CFO
    John J Winge, VP, Sales
    Troy Woolley, VP, Mktg.
    Tyler Lipschultz, VP, Orthobiologics & Bus. Dev.
  • Contact Info
  • SeaSpine Holdings Corp.
    Phone: (866) 942-8698
    5770 Armada Dr.
    Carlsbad, CA 92008
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register